Company Flexion Therapeutics, Inc.
Equities
FLXN
US33938J1060
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Compliance Officer | - | 16-08-31 | |
Scott A. Young
IRC | Investor Relations Contact | - | 16-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 50,321,366 | 48,104,888 ( 95.60 %) | 0 | 95.60 % |
Company contact information
Flexion Therapeutics, Inc.
10 Mall Road Suite 301
01803, Burlington
+781 305 7777
http://www.flexiontherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
-2.61% | 102B | |
+2.29% | 96.09B | |
+2.13% | 22.28B | |
-16.97% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.90% | 16.09B | |
+6.65% | 13.83B | |
+32.05% | 11.97B |